藥物洗脫支架 (DES) 市場:2023-2028 年全球行業趨勢、份額、規模、增長、機遇和預測
市場調查報告書
商品編碼
1206936

藥物洗脫支架 (DES) 市場:2023-2028 年全球行業趨勢、份額、規模、增長、機遇和預測

Drug-Eluting Stents Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

出版日期: | 出版商: IMARC | 英文 148 Pages | 商品交期: 2-3個工作天內

價格

2022年全球藥物洗脫支架市場規模將達到78億美元。 展望未來,IMARC Group 預測到 2028 年將達到 114 億美元,2023 年至 2028 年的增長率 (CAGR) 為 6.31%。

藥物洗脫支架 (DES) 是一種冠狀動脈裝置,用於在外周動脈和冠狀動脈中緩慢釋放藥物,以抑制細胞增殖並促進健康的血液流動。 它由金屬支架、聚合物塗層和抗再狹窄藥物組成。 支架上塗有藥物,有助於保持動脈潤滑並確保充足的血液流動。 DES 廣泛用於治療心臟動脈閉塞,防止斑塊積聚和血栓形成,並減少重複再灌注。 該支架微創 (MI),再狹窄率低,加速血管癒合,減少長期雙重抗血小板治療的需要。

藥物洗脫支架的市場趨勢

  • 患有慢性病的老年人口不斷增長是推動市場增長的關鍵因素之一。 DES 廣泛用於患動脈疾病的高風險患者,因為它有助於減少冠狀動脈旁路手術等侵入性手術的需要。 由於不健康的飲食習慣、缺乏運動、久坐不動的生活方式等,心血管疾病患病率上升也推動了市場增長。 此外,生物可吸收支架的推出等各種技術進步正在推動市場增長。 這些支架在體內很容易降解,降低了發生支架血栓的風險。 與此同時,無聚合物塗層支架的流行對市場增長產生了積極影響。 這些支架表現出更高的載藥能力和快速的藥物洗脫率。 預計將推動市場增長的其他因素包括異常心跳、心力衰竭和心髒病發作的發生率上升,以及公眾對 MI 技術的需求不斷增加。

主要市場細分

  • IMARC Group 分析了全球藥物洗脫支架市場報告和 2023 年至 2028 年全球、區域和國家層面預測的每個子部分的主要趨勢。 該報告根據塗層、藥劑、支架平台、世代、應用和最終用戶對市場進行分類。

塗層分解

  • 基於聚合物的塗層
  • 無聚合物塗層

按藥物分類

  • 西羅莫司
  • 紫杉醇
  • 佐他莫司
  • 依維莫司
  • 比奧利莫司
  • 其他

按支架平台細分

  • 不銹鋼
  • 鈷鉻
  • 白金鉻
  • 鎳鈦諾
  • 其他

按世代細分

  • 第一代
  • 第二代
  • 第三代
  • 第四代

按應用細分

  • 冠狀動脈疾病
  • 外周動脈疾病

最終用戶細分

  • 醫院
  • 門診手術中心
  • 其他

按地區劃分

  • 北美
  • 美國
  • 加拿大
  • 亞太地區
  • 中國
  • 日本
  • 印度
  • 韓國
  • 澳大利亞
  • 印度尼西亞
  • 其他
  • 歐洲
  • 德國
  • 法國
  • 英國
  • 意大利
  • 西班牙
  • 俄羅斯
  • 其他
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 其他
  • 中東和非洲

本報告中回答的關鍵問題

  • 1.2022年全球藥物洗脫支架市場規模有多大?
  • 2.2023-2028年全球藥物洗脫支架市場的預期增長率是多少?
  • 3. 推動全球藥物洗脫支架市場的關鍵因素是什麼?
  • 4.COVID-19 對全球藥物洗脫支架市場有何影響?
  • 5.5. 按塗層劃分的全球藥物洗脫支架市場情況如何?
  • 6.6. 按支架平台劃分的全球藥物洗脫支架市場情況如何?
  • 7. 全球藥物洗脫支架市場是如何按應用細分的?
  • 8. 全球藥物洗脫支架市場如何按最終用戶細分?
  • 9. 全球藥物洗脫支架市場的主要區域有哪些?
  • 10.10. 全球藥物洗脫支架市場的主要參與者/公司有哪些?

內容

第一章前言

第 2 章研究方法和範圍

  • 調查的目的
  • 利益相關者
  • 數據源
    • 主要信息
    • 次要信息
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章執行摘要

第四章介紹

  • 概覽
  • 主要行業趨勢

第 5 章藥物洗脫支架的全球市場

  • 市場概覽
  • 市場結果
  • COVID-19 的影響
  • 市場預測

第 6 章塗料市場細分

  • 基於聚合物的塗層
    • 市場趨勢
    • 市場展望
  • 無聚合物塗層
    • 市場趨勢
    • 市場展望

第 7 章藥物市場細分

  • 西羅莫司
    • 市場趨勢
    • 市場預測
  • 紫杉醇
    • 市場趨勢
    • 市場預測
  • 佐他莫司
    • 市場趨勢
    • 市場預測
  • 依維莫司
    • 市場趨勢
    • 市場預測
  • 比奧利莫司
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第 8 章支架平台市場細分

  • 由不銹鋼製成
    • 市場趨勢
    • 市場展望
  • 鈷鉻
    • 市場趨勢
    • 市場展望
  • 鉑鉻合金
    • 市場趨勢
    • 市場展望
  • 鎳鈦諾
    • 市場趨勢
    • 市場展望
  • 其他
    • 市場趨勢
    • 市場展望

第 9 章市場細分

  • 第一代
    • 市場趨勢
    • 市場預測
  • 第二代
    • 市場趨勢
    • 市場預測
  • 第三代
    • 市場趨勢
    • 市場預測
  • 第四代
    • 市場趨勢
    • 市場展望

第 10 章按應用劃分的市場細分

  • 冠狀動脈疾病
    • 市場趨勢
    • 市場預測
  • 外周動脈疾病
    • 市場趨勢
    • 市場預測

第 11 章最終用戶的市場細分

  • 醫院
    • 市場趨勢
    • 市場預測
  • 門診手術中心
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第 12 章區域市場細分

  • 北美
    • 美國
      • 市場趨勢
      • 市場預測
    • 加拿大
      • 市場趨勢
      • 市場展望
  • 亞太地區
    • 中國
      • 市場趨勢
      • 市場展望
    • 日本
      • 市場趨勢
      • 市場預測
    • 印度
      • 市場趨勢
      • 市場展望
    • 韓國市場
      • 市場趨勢
      • 市場展望
    • 澳大利亞
      • 市場趨勢
      • 市場展望
    • 印度尼西亞
      • 市場趨勢
      • 市場展望
    • 其他
      • 市場趨勢
      • 市場預測
  • 歐洲
    • 德國
      • 市場趨勢
      • 市場展望
    • 法國
      • 市場趨勢
      • 市場預測
    • 英國
      • 市場趨勢
      • 市場預測
    • 意大利
      • 市場趨勢
      • 市場展望
    • 西班牙
      • 市場趨勢
      • 市場展望
    • 俄羅斯
      • 市場趨勢
      • 市場展望
    • 其他
      • 市場趨勢
      • 市場預測
  • 拉丁美洲
    • 巴西
      • 市場趨勢
      • 市場展望
    • 墨西哥
      • 市場趨勢
      • 市場展望
    • 其他
      • 市場趨勢
      • 市場預測
  • 中東和非洲
    • 市場趨勢
    • 按國家/地區劃分的市場細分
    • 市場展望

第 13 章 SWOT 分析

  • 概覽
  • 強度
  • 弱點
  • 機會
  • 威脅

第14章價值鏈分析

第15章波特五力分析

  • 概覽
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第16章價格分析

第十七章競爭格局

  • 市場結構
  • 主要公司
  • 主要公司簡介
    • Abbott Laboratories
    • B. Braun Melsungen AG
    • Biosensors International Group Ltd.
    • Biotronik
    • Boston Scientific Corporation
    • Cardinal Health Inc.
    • Cook Medical LLC(Cook Group Incorporated)
    • Lepu Medical Technology(Beijing)Co. Ltd.
    • Medtronic plc
    • MicroPort Scientific Corporation
    • Sino Medical Sciences Technology Inc.
    • Terumo Corporation
Product Code: SR1323A408_Report

The global drug-eluting stents market size reached US$ 7.8 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 11.4 Billion by 2028, exhibiting a growth rate (CAGR) of 6.31% during 2023-2028.

A drug-eluting stent (DES) is a coronary device that is used for the slow release of drugs in peripheral or coronary arteries to block cell proliferation and promote a healthy flow of blood. It consists of a metallic stent, polymer coating and anti-restenosis drug. The stent is coated with medications that assist the arteries to remain smooth and ensure adequate blood flow. DES is widely used to treat blockages in heart arteries, prevent plaque buildup, blood clots and reduce repeated revascularization. The stent is minimally invasive (MI) and offers lower restenosis rates, enhanced vessel healing and reduced need for prolonged dual antiplatelet therapy.

Drug-Eluting Stents Market Trends:

  • The rising geriatric population prone to chronic medical ailments is one of the key factors driving the growth of the market. DES is widely utilized in patients with a high risk of developing arterial disorders as the stents aid in reducing the need for invasive procedures, such as coronary artery bypass surgeries. Additionally, the increasing prevalence of cardiovascular diseases due to the unhealthy dietary patterns, lack of physical activity and sedentary lifestyles of the masses is favoring the market growth. Moreover, various technological advancements, such as the launch of bioresorbable stents, are providing a thrust to the market growth. These stents are easily dissolvable in the body and reduce the risk of developing stent thrombosis. In line with this, the widespread adoption of stents with polymer-free coatings is positively impacting the market growth. These stents exhibit a higher drug loading capacity and quicker drug-eluting rate. Other factors, including the rising incidence of abnormal heart rhythms, heart failure and heart attack disease, along with the increasing demand for MI techniques among the masses, are anticipated to drive the market toward growth.

Key Market Segmentation:

  • IMARC Group provides an analysis of the key trends in each sub-segment of the global drug-eluting stents market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on coating, drug, stent platform, generation, application and end user.

Breakup by Coating:

  • Polymer Based Coating
  • Polymer Free Coating

Breakup by Drug:

  • Sirolimus
  • Paclitaxel
  • Zotarolimus
  • Everolimus
  • Biolimus
  • Others

Breakup by Stent Platform:

  • Stainless-steel
  • Cobalt-Chromium
  • Platinum-Chromium
  • Nitinol
  • Others

Breakup by Generation:

  • 1st Generation
  • 2nd Generation
  • 3rd Generation
  • 4th Generation

Breakup by Application:

  • Coronary Artery Disease
  • Peripheral Artery Disease

Breakup by End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

  • The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, B. Braun Melsungen AG, Biosensors International Group Ltd., Biotronik, Boston Scientific Corporation, Cardinal Health Inc., Cook Medical LLC (Cook Group Incorporated), Lepu Medical Technology (Beijing) Co. Ltd., Medtronic plc, MicroPort Scientific Corporation, Sino Medical Sciences Technology Inc. and Terumo Corporation.

Key Questions Answered in This Report:

  • 1. What was the size of the global drug-eluting stents market in 2022?
  • 2. What is the expected growth rate of the global drug-eluting stents market during 2023-2028?
  • 3. What are the key factors driving the global drug-eluting stents market?
  • 4. What has been the impact of COVID-19 on the global drug-eluting stents market?
  • 5. What is the breakup of the global drug-eluting stents market based on the coating?
  • 6. What is the breakup of the global drug-eluting stents market based on the stent platform?
  • 7. What is the breakup of the global drug-eluting stents market based on the application?
  • 8. What is the breakup of the global drug-eluting stents market based on the end user?
  • 9. What are the key regions in the global drug-eluting stents market?
  • 10. Who are the key players/companies in the global drug-eluting stents market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Drug-Eluting Stents Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Coating

  • 6.1 Polymer Based Coating
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Polymer Free Coating
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Drug

  • 7.1 Sirolimus
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Paclitaxel
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Zotarolimus
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Everolimus
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Biolimus
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Others
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by Stent Platform

  • 8.1 Stainless-steel
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Cobalt-Chromium
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Platinum-Chromium
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Nitinol
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by Generation

  • 9.1 1st Generation
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 2nd Generation
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 3rd Generation
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 4th Generation
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Application

  • 10.1 Coronary Artery Disease
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Peripheral Artery Disease
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast

11 Market Breakup by End User

  • 11.1 Hospitals
    • 11.1.1 Market Trends
    • 11.1.2 Market Forecast
  • 11.2 Ambulatory Surgical Centers
    • 11.2.1 Market Trends
    • 11.2.2 Market Forecast
  • 11.3 Others
    • 11.3.1 Market Trends
    • 11.3.2 Market Forecast

12 Market Breakup by Region

  • 12.1 North America
    • 12.1.1 United States
      • 12.1.1.1 Market Trends
      • 12.1.1.2 Market Forecast
    • 12.1.2 Canada
      • 12.1.2.1 Market Trends
      • 12.1.2.2 Market Forecast
  • 12.2 Asia-Pacific
    • 12.2.1 China
      • 12.2.1.1 Market Trends
      • 12.2.1.2 Market Forecast
    • 12.2.2 Japan
      • 12.2.2.1 Market Trends
      • 12.2.2.2 Market Forecast
    • 12.2.3 India
      • 12.2.3.1 Market Trends
      • 12.2.3.2 Market Forecast
    • 12.2.4 South Korea
      • 12.2.4.1 Market Trends
      • 12.2.4.2 Market Forecast
    • 12.2.5 Australia
      • 12.2.5.1 Market Trends
      • 12.2.5.2 Market Forecast
    • 12.2.6 Indonesia
      • 12.2.6.1 Market Trends
      • 12.2.6.2 Market Forecast
    • 12.2.7 Others
      • 12.2.7.1 Market Trends
      • 12.2.7.2 Market Forecast
  • 12.3 Europe
    • 12.3.1 Germany
      • 12.3.1.1 Market Trends
      • 12.3.1.2 Market Forecast
    • 12.3.2 France
      • 12.3.2.1 Market Trends
      • 12.3.2.2 Market Forecast
    • 12.3.3 United Kingdom
      • 12.3.3.1 Market Trends
      • 12.3.3.2 Market Forecast
    • 12.3.4 Italy
      • 12.3.4.1 Market Trends
      • 12.3.4.2 Market Forecast
    • 12.3.5 Spain
      • 12.3.5.1 Market Trends
      • 12.3.5.2 Market Forecast
    • 12.3.6 Russia
      • 12.3.6.1 Market Trends
      • 12.3.6.2 Market Forecast
    • 12.3.7 Others
      • 12.3.7.1 Market Trends
      • 12.3.7.2 Market Forecast
  • 12.4 Latin America
    • 12.4.1 Brazil
      • 12.4.1.1 Market Trends
      • 12.4.1.2 Market Forecast
    • 12.4.2 Mexico
      • 12.4.2.1 Market Trends
      • 12.4.2.2 Market Forecast
    • 12.4.3 Others
      • 12.4.3.1 Market Trends
      • 12.4.3.2 Market Forecast
  • 12.5 Middle East and Africa
    • 12.5.1 Market Trends
    • 12.5.2 Market Breakup by Country
    • 12.5.3 Market Forecast

13 SWOT Analysis

  • 13.1 Overview
  • 13.2 Strengths
  • 13.3 Weaknesses
  • 13.4 Opportunities
  • 13.5 Threats

14 Value Chain Analysis

15 Porters Five Forces Analysis

  • 15.1 Overview
  • 15.2 Bargaining Power of Buyers
  • 15.3 Bargaining Power of Suppliers
  • 15.4 Degree of Competition
  • 15.5 Threat of New Entrants
  • 15.6 Threat of Substitutes

16 Price Analysis

17 Competitive Landscape

  • 17.1 Market Structure
  • 17.2 Key Players
  • 17.3 Profiles of Key Players
    • 17.3.1 Abbott Laboratories
      • 17.3.1.1 Company Overview
      • 17.3.1.2 Product Portfolio
      • 17.3.1.3 Financials
      • 17.3.1.4 SWOT Analysis
    • 17.3.2 B. Braun Melsungen AG
      • 17.3.2.1 Company Overview
      • 17.3.2.2 Product Portfolio
      • 17.3.2.3 SWOT Analysis
    • 17.3.3 Biosensors International Group Ltd.
      • 17.3.3.1 Company Overview
      • 17.3.3.2 Product Portfolio
    • 17.3.4 Biotronik
      • 17.3.4.1 Company Overview
      • 17.3.4.2 Product Portfolio
      • 17.3.4.3 SWOT Analysis
    • 17.3.5 Boston Scientific Corporation
      • 17.3.5.1 Company Overview
      • 17.3.5.2 Product Portfolio
      • 17.3.5.3 Financials
      • 17.3.5.4 SWOT Analysis
    • 17.3.6 Cardinal Health Inc.
      • 17.3.6.1 Company Overview
      • 17.3.6.2 Product Portfolio
      • 17.3.6.3 Financials
      • 17.3.6.4 SWOT Analysis
    • 17.3.7 Cook Medical LLC (Cook Group Incorporated)
      • 17.3.7.1 Company Overview
      • 17.3.7.2 Product Portfolio
      • 17.3.7.3 SWOT Analysis
    • 17.3.8 Lepu Medical Technology (Beijing) Co. Ltd.
      • 17.3.8.1 Company Overview
      • 17.3.8.2 Product Portfolio
      • 17.3.8.3 Financials
    • 17.3.9 Medtronic plc
      • 17.3.9.1 Company Overview
      • 17.3.9.2 Product Portfolio
      • 17.3.9.3 Financials
      • 17.3.9.4 SWOT Analysis
    • 17.3.10 MicroPort Scientific Corporation
      • 17.3.10.1 Company Overview
      • 17.3.10.2 Product Portfolio
    • 17.3.11 Sino Medical Sciences Technology Inc.
      • 17.3.11.1 Company Overview
      • 17.3.11.2 Product Portfolio
    • 17.3.12 Terumo Corporation
      • 17.3.12.1 Company Overview
      • 17.3.12.2 Product Portfolio
      • 17.3.12.3 Financials
      • 17.3.12.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Drug-Eluting Stents Market: Major Drivers and Challenges
  • Figure 2: Global: Drug-Eluting Stents Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Drug-Eluting Stents Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Drug-Eluting Stents Market: Breakup by Coating (in %), 2022
  • Figure 5: Global: Drug-Eluting Stents Market: Breakup by Drug (in %), 2022
  • Figure 6: Global: Drug-Eluting Stents Market: Breakup by Stent Platform (in %), 2022
  • Figure 7: Global: Drug-Eluting Stents Market: Breakup by Generation (in %), 2022
  • Figure 8: Global: Drug-Eluting Stents Market: Breakup by Application (in %), 2022
  • Figure 9: Global: Drug-Eluting Stents Market: Breakup by End User (in %), 2022
  • Figure 10: Global: Drug-Eluting Stents Market: Breakup by Region (in %), 2022
  • Figure 11: Global: Drug-Eluting Stents (Polymer Based Coating) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 12: Global: Drug-Eluting Stents (Polymer Based Coating) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 13: Global: Drug-Eluting Stents (Polymer Free Coating) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 14: Global: Drug-Eluting Stents (Polymer Free Coating) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 15: Global: Drug-Eluting Stents (Sirolimus) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 16: Global: Drug-Eluting Stents (Sirolimus) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 17: Global: Drug-Eluting Stents (Paclitaxel) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 18: Global: Drug-Eluting Stents (Paclitaxel) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 19: Global: Drug-Eluting Stents (Zotarolimus) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 20: Global: Drug-Eluting Stents (Zotarolimus) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 21: Global: Drug-Eluting Stents (Everolimus) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 22: Global: Drug-Eluting Stents (Everolimus) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 23: Global: Drug-Eluting Stents (Biolimus) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 24: Global: Drug-Eluting Stents (Biolimus) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 25: Global: Drug-Eluting Stents (Other Drugs) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 26: Global: Drug-Eluting Stents (Other Drugs) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 27: Global: Drug-Eluting Stents (Stainless-steel) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 28: Global: Drug-Eluting Stents (Stainless-steel) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 29: Global: Drug-Eluting Stents (Cobalt-Chromium) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 30: Global: Drug-Eluting Stents (Cobalt-Chromium) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 31: Global: Drug-Eluting Stents (Platinum-Chromium) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 32: Global: Drug-Eluting Stents (Platinum-Chromium) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 33: Global: Drug-Eluting Stents (Nitinol) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 34: Global: Drug-Eluting Stents (Nitinol) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 35: Global: Drug-Eluting Stents (Other Stent Platforms) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 36: Global: Drug-Eluting Stents (Other Stent Platforms) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 37: Global: Drug-Eluting Stents (1st Generation) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 38: Global: Drug-Eluting Stents (1st Generation) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 39: Global: Drug-Eluting Stents (2nd Generation) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 40: Global: Drug-Eluting Stents (2nd Generation) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 41: Global: Drug-Eluting Stents (3rd Generation) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 42: Global: Drug-Eluting Stents (3rd Generation) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 43: Global: Drug-Eluting Stents (4th Generation) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 44: Global: Drug-Eluting Stents (4th Generation) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 45: Global: Drug-Eluting Stents (Coronary Artery Disease) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 46: Global: Drug-Eluting Stents (Coronary Artery Disease) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 47: Global: Drug-Eluting Stents (Peripheral Artery Disease) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 48: Global: Drug-Eluting Stents (Peripheral Artery Disease) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 49: Global: Drug-Eluting Stents (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 50: Global: Drug-Eluting Stents (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 51: Global: Drug-Eluting Stents (Ambulatory Surgical Centers) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 52: Global: Drug-Eluting Stents (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 53: Global: Drug-Eluting Stents (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 54: Global: Drug-Eluting Stents (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 55: North America: Drug-Eluting Stents Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 56: North America: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 57: United States: Drug-Eluting Stents Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 58: United States: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 59: Canada: Drug-Eluting Stents Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 60: Canada: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 61: Asia-Pacific: Drug-Eluting Stents Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 62: Asia-Pacific: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 63: China: Drug-Eluting Stents Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 64: China: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 65: Japan: Drug-Eluting Stents Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 66: Japan: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 67: India: Drug-Eluting Stents Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 68: India: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 69: South Korea: Drug-Eluting Stents Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 70: South Korea: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 71: Australia: Drug-Eluting Stents Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 72: Australia: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 73: Indonesia: Drug-Eluting Stents Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 74: Indonesia: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 75: Others: Drug-Eluting Stents Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 76: Others: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 77: Europe: Drug-Eluting Stents Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 78: Europe: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 79: Germany: Drug-Eluting Stents Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 80: Germany: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 81: France: Drug-Eluting Stents Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 82: France: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 83: United Kingdom: Drug-Eluting Stents Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 84: United Kingdom: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 85: Italy: Drug-Eluting Stents Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 86: Italy: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 87: Spain: Drug-Eluting Stents Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 88: Spain: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 89: Russia: Drug-Eluting Stents Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 90: Russia: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 91: Others: Drug-Eluting Stents Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 92: Others: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 93: Latin America: Drug-Eluting Stents Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 94: Latin America: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 95: Brazil: Drug-Eluting Stents Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 96: Brazil: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 97: Mexico: Drug-Eluting Stents Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 98: Mexico: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 99: Others: Drug-Eluting Stents Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 100: Others: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 101: Middle East and Africa: Drug-Eluting Stents Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 102: Middle East and Africa: Drug-Eluting Stents Market: Breakup by Country (in %), 2022
  • Figure 103: Middle East and Africa: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 104: Global: Drug-Eluting Stents Industry: SWOT Analysis
  • Figure 105: Global: Drug-Eluting Stents Industry: Value Chain Analysis
  • Figure 106: Global: Drug-Eluting Stents Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Drug-Eluting Stents Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Drug-Eluting Stents Market Forecast: Breakup by Coating (in Million US$), 2023-2028
  • Table 3: Global: Drug-Eluting Stents Market Forecast: Breakup by Drug (in Million US$), 2023-2028
  • Table 4: Global: Drug-Eluting Stents Market Forecast: Breakup by Stent Platform (in Million US$), 2023-2028
  • Table 5: Global: Drug-Eluting Stents Market Forecast: Breakup by Generation (in Million US$), 2023-2028
  • Table 6: Global: Drug-Eluting Stents Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 7: Global: Drug-Eluting Stents Market Forecast: Breakup by End User (in Million US$), 2023-2028
  • Table 8: Global: Drug-Eluting Stents Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 9: Global: Drug-Eluting Stents Market: Competitive Structure
  • Table 10: Global: Drug-Eluting Stents Market: Key Players